Firebrick Pharma Limited (AU:FRE) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Firebrick Pharma Limited announced the successful passing of all resolutions at its recent Annual General Meeting, including special resolutions on the 7.1A Mandate and an amendment to the constitution. The company, known for its innovative povidone-iodine nasal spray, continues to show progress with its clinical trials and product development. This positive momentum could interest investors looking at potential growth in the pharmaceutical sector.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.